Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
REGN
#239
Regeneron Pharmaceuticals, Inc. - Common Stock
664.4
5
USD
+0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.27%
Monthly Change
+8.01%
6 month change
-8.73%
Year Change
+21.77%
Previous Close
656.1
2
Open
664.3
4
Low
664.3
4
High
664.4
5
Volume
214
Markets
US Stock Market
Healthcare
Biotechnology
REGN
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
106.15 M
104.17 M
103.28 M
103.9 M
103.02 M
104.84 M
Valuation ratios
Enterprise value
67.37 B
55.63 B
58.57 B
80.47 B
80.75 B
68.25 B
Price to earnings ratio
16.12
13.21
13.45
18.61
18.86
16.12
Price to sales ratio
5.15
4.17
4.39
5.84
5.59
4.78
Price to cash flow ratio
18.36
12.49
12.22
16.84
16.64
14.22
Price to book ratio
0.62
0.5
0.52
2.68
0.68
0.58
Enterprise value to EBITDA ratio
15.57
12.79
13.9
19.52
18.72
16.37
Profitability ratios
Return on assets %
0.02
0.04
0.04
0.02
0.02
0.02
Return on equity %
0.03
0.05
0.05
0.03
0.02
0.02
Return on invested capital %
7.73
13.18
11.18
9.51
7.48
7.48
Gross margin %
100
100
100
100
100
100
Operating margin %
19.54
29.37
27.35
22.65
17.83
17.83
EBITDA margin %
23.73
33.04
30.99
26.39
21.25
21.25
Net margin %
26.7
37.86
38.89
21.74
20.17
20.17
Liquidity ratios
Quick ratio
4.03
3.72
3.33
3.39
2.96
2.96
Current ratio
4.93
4.6
4.06
4.13
3.57
3.57
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.08
0.1
0.1
0.1
0.09
0.09
Solvency ratios
Debt to assets ratio
0.05
0.05
0.05
0.05
0.05
0.05
Debt to equity ratio
0.07
0.07
0.06
0.06
0.06
0.06
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
9.4
10.54
15.1
10.78
10.02
46.44
EBIT per share
5.32
9.94
9.58
8.1
5.97
33.59
EBITDA per share
6.46
11.18
10.85
9.44
7.11
38.59
Total debt per share
17.85
18.28
18.52
18.29
25.13
18.44
Cash per share
75.08
68.78
78.76
79.24
81.28
81.28
Net current asset value per share
158.02
155.24
167.73
165.95
169.07
169.07
Tangible book value per share
264.28
275.68
288.79
287.82
291.77
291.77
Working capital per share
125.95
121.48
126.45
125.72
121.65
121.65
Book value per share
264.28
275.68
288.79
287.82
291.77
291.77
News
Longleaf Partners Global Fund Q2 2026 Portfolio Review
Baird International And Global Growth Funds Q2 2026 Contributors And Detractors
These biggest and ‘least loved’ stocks are the ones to pick ahead of earnings
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry (NYSE:NVO)
Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?
Here's Why Regeneron (REGN) is a Strong Value Stock
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Can Alnylam's Drug Pipeline Fuel Its Long-Term Revenue Growth?
Why Regeneron (REGN) is a Top Momentum Stock for the Long-Term
What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week?
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It (NYSEARCA:XLV)